ROBIN PINGETON: Open Payments
NPI 1154465425 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,608 in 17 payments from 9 companies in 2025. Trend: 2023 $2,352 · 2024 $1,658 · 2025 $1,608
Food & beverage: $1,492Honoraria: $115
| Company | Payments | Amount |
|---|---|---|
| Alpha Cognition USA, Inc. | 3 | $301 |
| SANOFI-AVENTIS U.S. LLC | 3 | $290 |
| SCPHARMACEUTICALS INC. | 2 | $282 |
| Tris Pharma Inc | 3 | $183 |
| Neurocrine BioSciences, Inc. | 1 | $136 |
| Kowa Pharmaceuticals America, Inc. | 1 | $120 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $110 |
| Axsome Therapeutics, Inc. | 1 | $109 |
| Otsuka America Pharmaceutical, Inc. | 2 | $76 |
Products named: Zunveyl, TZIELD, FUROSCIX, Dyanavel XR, ZORYVE, Auvelity, REXULTI.
Industry payments across GA — which companies pay providers there.
